Coronavirus Update: FDA Provides Updated Guidance to Address the Urgent Need for Blood During the Pandemic
April 03, 2020
April 03, 2020
WASHINGTON, April 3 -- The U.S. Department of Health and Human Services' Food and Drug Administration issued the following statement by Peter Marks, director of Center for Biologics Evaluation and Research on April 2:
"As part of the U.S. Food and Drug Administration's ongoing commitment to fight the Coronavirus Disease 2019 (COVID-19) pandemic, today the agency issued guidance for immediate implementation to address the urgent and immediate need for blood and blood components. . . .
"As part of the U.S. Food and Drug Administration's ongoing commitment to fight the Coronavirus Disease 2019 (COVID-19) pandemic, today the agency issued guidance for immediate implementation to address the urgent and immediate need for blood and blood components. . . .